# NMN, NAD and Longevity — Facebook Reel source note (2026-06-05)

## Social clip captured

- Platform: Facebook Reel
- Canonical URL: https://www.facebook.com/reel/971079585630556
- Shared URL supplied by Chris: https://www.facebook.com/share/r/14kojewgfLR/?mibextid=wwXIfr
- Account/page visible in browser: The Longevity Experts
- Visible engagement at capture: about 8.1K views, 50 reactions, 11 comments, 13 shares
- Visible caption theme: David Sinclair explains why scientists are interested in NAD, NMN and NR; the post invites viewers to comment `NEWS` for a private longevity newsletter.
- Local transcript: `research/health/nmn-nad-longevity-facebook-reel-transcript-2026-06-05.txt`
- Local source frame: `assets/images/health/nmn-nad-longevity-facebook-reel.jpg`
- Local metadata JSON: `research/health/nmn-nad-longevity-facebook-reel-facebook-meta-2026-06-05.json`

## What the clip claims

The clip says NAD levels decline with age, which has led researchers to investigate NAD precursors/boosters such as NMN and NR. It says animal studies have reported restored NAD levels, enhanced insulin sensitivity, less frailty, better mitochondrial function and higher activity. It also cites Yoshino et al. 2021 as an early randomized placebo-controlled human NMN study showing improved insulin-stimulated glucose disposal.

## Transcript excerpt

```text
[0.00-3.00] Because NAD levels decline as we age,
[3.00-6.04] researchers have spent years asking an important question.
[6.04-8.04] Can we restore those levels?
[8.04-10.40] And in doing so, support the body's natural
[10.40-11.48] longevity pathways.
[11.48-14.56] That's what led to a growing interest in NAD precursors
[14.56-17.44] or NAD boosters like NMN and NR.
[17.44-18.48] When it comes to NMN,
[18.48-21.52] there's been a number of animal studies showing,
[21.52-23.52] for instance, it restores NAD levels,
[23.52-26.20] it enhances insulin sensitivity.
[26.20-29.68] The machine in my eyes showed that it actually was pretty good
[29.68-31.44] at slowing down the effects of aging.
[31.44-33.20] We've been doing these studies for the last few years
[33.20-34.04] in my life.
[34.04-36.40] Now, preliminary, these mice have less frailty.
[36.40-39.48] We've reported that out in the scientific community.
[39.48-42.16] They seem to be younger, having better activity,
[42.16-44.12] better mitochondrial function, they run further.
[44.12-45.20] The lifespan looks promising.
[45.20-47.68] What are we seeing in the human studies for NMN?
[47.68-49.00] Early results, for instance,
[49.00-52.04] from Yoshino et al in 2021,
[52.04-55.48] showed increased insulin's demulated glucose disposal.
[55.48-57.44] You were pretty excited about it, tell me why.
[57.44-58.76] That's one of the first real proofs
[58.76-62.08] that NMN does something in humans the way it works in mice.
[62.08-63.40] So this was a 10 week study.
[63.40-64.32] It's well done.
[64.32-65.96] It's randomized placebo controlled.
[65.96-68.92] It was 250 milligrams, which is a relatively low dose.
```

## Source trail checked

- PubMed PMID 33888596 — Yoshino et al., *Science* 2021, “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.” DOI: 10.1126/science.abe9985. https://pubmed.ncbi.nlm.nih.gov/33888596/
- PubMed PMID 37619764 — *Advances in Nutrition* 2023 review, “The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.” DOI: 10.1016/j.advnut.2023.08.008. https://pubmed.ncbi.nlm.nih.gov/37619764/
- PubMed PMID 37478182 — *Science Advances* 2023, “What is really known about the effects of nicotinamide riboside supplementation in humans.” DOI: 10.1126/sciadv.adi4862. https://pubmed.ncbi.nlm.nih.gov/37478182/
- PubMed PMID 29599478 — *Nature Communications* 2018, “Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.” https://pubmed.ncbi.nlm.nih.gov/29599478/
- PubMed PMID 31412242 — human skeletal-muscle NR study: “Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome…” https://pubmed.ncbi.nlm.nih.gov/31412242/
- PubMed PMID 40926126 — *Nature Aging* 2025 review, “Emerging strategies, applications and challenges of targeting NAD+ in the clinic.” https://pubmed.ncbi.nlm.nih.gov/40926126/

## Evidence labels

- Verified: NAD biology is a real longevity/metabolism research area.
- Verified: Yoshino et al. 2021 was a randomized placebo-controlled human NMN trial in a specific population: postmenopausal women with prediabetes.
- Supported but limited: NMN/NR can raise NAD-related metabolites in some human studies and may affect selected metabolic markers.
- Still uncertain: whether NMN or NR meaningfully slows human aging, extends lifespan, prevents disease, or is safe/effective as a decades-long consumer anti-aging strategy.
- Marketing risk: the Reel is attached to a newsletter lead magnet and compresses early science into a promotional social-media format.

## Managing Expectations framing

Useful public line: **NAD boosters are real science, but not proven age-reversal medicine.** The Reel is more careful than many supplement clips, but it still needs the usual separation between mouse results, short human biomarker trials, and proven long-term health outcomes.